If you are a member, you may get the Consumer Assessment of Healthcare Providers (CAHPS) survey in the mail. The CAHPS survey is delivered March through June each year to get insight about your experiences over the past six months.
The survey asks members to rate the health plan, the health plan quality, and the drug plan, as well as provide feedback in several areas including:
Members are chosen to participate at random. To be eligible to participate if selected, you must meet some criteria, including being enrolled in a Medicare Advantage plan or a Prescription Drug plan for at least six months. If selected, you will first receive a pre-notification letter and then the survey will mail separately the following week. If your completed survey is not received, you may also receive a follow-up mailing, inclusive of the survey.
Your responses help us to know what we're doing well and how we can serve you better. If selected, please complete the survey. Your feedback is appreciated. And remember – if you have questions or problems at any time, call the Customer Service phone number on the back of your member ID card. We'll be happy to help you!
Important Plan Information
SIGN IN to share your comments or REGISTER today to become a Connect member.
A Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association. © Copyright 2019 Health Care Service Corporation. All Rights Reserved.
Telligent is an operating division of Verint Americas, Inc., an independent company that provides and hosts an online community platform for blogging and access to social media for Blue Cross and Blue Shield of New Mexico.
File is in portable document format (PDF). To view this file, you may need to install a PDF reader program. Most PDF readers are a free download. One option is Adobe® Reader® which has a built-in screen reader. Other Adobe accessibility tools and information can be downloaded at http://access.adobe.com.
Last Updated 10012018Y0096_WEB_NM_CONNECT19_C